(PharmaNewsWire.Com, April 23, 2018 ) Publisher’s market study identifies the increasing prevalence of digestive problems to be one of the primary growth factors for the feminine probiotic supplement market. Human microbiome, consisting of both good and bad bacteria, is primarily located in the GI tract. For proper digestion, it is essential for the intestinal flora to have an equal balance of good and bad bacteria. Due to unhealthy lifestyles such as heavy consumption of alcohol, frequent use of antibiotics, and poor diet, the intestinal bacterial flora is affected and results in digestive disorders. The rising instances of digestive problems among the population will drive the requirement for probiotic pills. These probiotic supplements aid in modulating the gut flora and support a healthy GI lining, consequently, improving the ability of the body to digest and metabolize nutrients that are essential for individual health and well-being. Our market analysts estimate that the market will grow steadily at a CAGR of greater than 7% by 2022.
Covered in this report The report covers the present scenario and the growth prospects of the global feminine probiotic supplement market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Feminine Probiotic Supplement Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors - Bayer - Chr. Hansen Holding - Church & Dwight Co. - DowDuPont - Koninklijke DSM N.V. - Probi AB
Market driver - Increasing prevalence of digestive problems - For a full, detailed list, view our report
Market challenge - Presence of stringent government regulations and guidelines - For a full, detailed list, view our report
Market trend - Growing emphasis on R&D - For a full, detailed list, view our report
Table of Contents
PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE PART 05: MARKET SIZING PART 06: FIVE FORCES ANALYSIS PART 07: MARKET SEGMENTATION PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES PART 12: MARKET TRENDS PART 13: VENDOR LANDSCAPE PART 14: VENDOR ANALYSIS PART 15: APPENDIX
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
